SciTransfer
Organization

UNIVERSIDADE DO MINHO

Portuguese university strong in tissue engineering, biomaterials, and open science, with growing capacity in graphene, brain simulation, and sustainability research.

University research grouphealthPT
H2020 projects
98
As coordinator
23
Total EC funding
€38.4M
Unique partners
1107
What they do

Their core work

Universidade do Minho is a Portuguese research university with deep strengths in biomaterials, tissue engineering, and regenerative medicine — designing scaffolds, bioprinted constructs, and cell-based therapies for skin, tendon, and disease modeling. They are also a significant contributor to European open science infrastructure (OpenAIRE, EOSC) and research data management. More recently, they have expanded into computational neuroscience through the Human Brain Project and into advanced materials via the Graphene Flagship, positioning themselves at the intersection of life sciences and high-performance computing.

Core expertise

What they specialise in

Tissue engineering & regenerative medicineprimary
12 projects

Core theme across FoReCaST (3D cancer models), Gene2Skin (skin therapies), PrinTendon (bioprinted tendon), ATLAS, ELASTISLET, Tendon Therapy Train, and UNICAT (biomaterial catheters).

8 projects

Sustained involvement in OpenAIRE2020, RItrain, and multiple CSA projects focused on open access infrastructure, research information systems, and EOSC development.

Graphene & advanced materialssecondary
5 projects

Participation in GrapheneCore1 and related projects on graphene-based technologies, 2D materials for semiconductor inks, and self-healing materials.

Sustainability & green chemistryemerging
4 projects

Recent keyword clusters around sustainability, global changes, green chemistry, polyphenols, and bio-derived volatile fatty acids (VOLATILE project).

Responsible research & science-society engagementsecondary
5 projects

Multiple projects on responsible research and innovation (SCILIFE, EQUAL-IST, RISEWISE, EXCHANGE) addressing gender equality, disability inclusion, and forensic genetics ethics.

Evolution & trajectory

How they've shifted over time

Early focus
Regenerative medicine & open science
Recent focus
Advanced materials & computational neuroscience

In the early H2020 period (2014–2018), UMinho concentrated heavily on regenerative medicine, biomaterials, and building European open science infrastructure — keywords like "precision medicine," "scaffold," "open access infrastructure," and "research information system" dominated. From 2018 onward, the portfolio broadened significantly: graphene, computational neuroscience (human brain simulation, neuromorphic computing), sustainability, and numerical modelling became prominent. This signals a deliberate expansion from wet-lab biomedical research toward computational methods and materials science with environmental applications.

UMinho is moving toward computationally intensive, materials-driven research — expect future proposals combining biomaterials with simulation, digital twins, or sustainability-focused advanced materials.

Collaboration profile

How they like to work

Role: active_partnerReach: Global54 countries collaborated

UMinho operates primarily as an active partner (68 of 98 projects), but has meaningful coordination experience with 23 projects led — a strong ratio for a Southern European university. With 1,107 unique consortium partners across 54 countries, they are a genuine network hub rather than a repeat-partner institution. Their high CSA count (21 projects) shows they are frequently trusted for coordination support activities, policy engagement, and infrastructure building — not just technical deliverables.

UMinho has collaborated with over 1,100 unique partners across 54 countries, making them one of the most broadly networked Portuguese universities in H2020. Their geographic spread is genuinely pan-European with global reach, not clustered around Iberian or Southern European partners.

Why partner with them

What sets them apart

UMinho's rare combination of biomaterials/tissue engineering expertise with strong open science credentials and involvement in flagship programs (Graphene, Human Brain Project) makes them unusually versatile for a mid-sized Portuguese university. They can contribute to both wet-lab experimental work and large-scale computational or infrastructure projects. For consortium builders, they offer a Widening country partner that punches well above its weight — 98 H2020 projects and EUR 38M in funding signals proven capacity and reliability.

Notable projects

Highlights from their portfolio

  • FoReCaST
    Largest coordinated project (EUR 2.5M) — established UMinho as a leader in 3D cancer disease models for drug screening, a Widening-funded initiative.
  • EXCHANGE
    EUR 1.35M coordinated project on forensic DNA data exchange across the EU, demonstrating unusual breadth beyond biomedical engineering into science-society-law intersections.
  • HBP SGA1
    Participation in the Human Brain Project flagship — one of Europe's largest research initiatives — connecting UMinho to top-tier neuroscience and HPC communities.
Cross-sector capabilities
Digital (HPC, neuromorphic computing, brain simulation)Manufacturing (advanced materials, graphene, self-healing composites)Environment (sustainability, green chemistry, circular economy)Society (responsible research, science engagement, gender equality)
Analysis note: Profile based on 30 of 98 projects shown in detail plus aggregate analytics. The remaining 68 projects would likely reinforce the identified patterns given the keyword and sector distributions. High confidence in primary expertise areas; cross-sector capabilities may be slightly understated.